The UK’s Medicines and Healthcare products Regulatory Agency GCP Inspectorate conducted 125 GCP inspections between April 1, 2013, and March 31, 2014, yielding only two critical findings and 56 major findings among 22 commercial sponsors, according to the agency’s GCP Inspections Metrics Report.
Source: Clinical Trials Advisor